Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam for prevention of post-dural puncture headache after diagnostic lumbar puncture
IRCT20180205038631N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in post-dural puncture headache (PDPH) comparing Midazolam with Placebo (2 arms). Primary endpoints: Rate of post-dural puncture headache, Severity of post-dural puncture headache and 2 more. Started May 2018; status: completed.
02
Drugs
midazolam
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20180205038631N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180205038631N1.